ArticleGynecologic oncology2022
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy.
Tenley R Klc et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleGynecologic oncology2022
Tenley R Klc et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.